Erratum to “The public health impact of the Rx-to-OTC switch of triptan in Germany: Systematic review and framework analysis” [JAPH 65/5 (2025) 102489]

IF 2.5 4区医学 Q3 PHARMACOLOGY & PHARMACY

Journal of the American Pharmacists Association Pub Date : 2026-01-01 Epub Date: 2025-09-17 DOI:10.1016/j.japh.2025.102923

引用次数: 0

查看原文本刊更多论文

《曲坦类药物在德国从处方药转向otc的公共卫生影响：系统回顾和框架分析》[JAPH 65/5(2025) 102489]的勘误。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of the American Pharmacists Association 医学-药学

CiteScore

3.30

自引率

14.30%

发文量

336

审稿时长

46 days

期刊介绍： The Journal of the American Pharmacists Association is the official peer-reviewed journal of the American Pharmacists Association (APhA), providing information on pharmaceutical care, drug therapy, diseases and other health issues, trends in pharmacy practice and therapeutics, informed opinion, and original research. JAPhA publishes original research, reviews, experiences, and opinion articles that link science to contemporary pharmacy practice to improve patient care.